|

Non-mavacamten symptomatic oHCM therapy Clinical Trials

1 actively recruiting trial across 1 location

Top Sponsors

  • Bristol-Myers Squibb1

Indications

  • Obstructive Hypertrophic Cardiomyopathy1
  • Heart Disease1

Anchorage, Alaska1 trial

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Alaska Heart Institute

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.